Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Oct 22, 2022
Date Accepted: Jul 18, 2023

The final, peer-reviewed published version of this preprint can be found here:

The Impact of Metabolic Syndrome Risk Factors on Lung Function Impairment: Cross-Sectional Study

Molina-Luque R, Molina-Recio G, de Pedro–Jiménez D, Álvarez–Fernández C, García–Rodríguez M, Romero-Saldaña M

The Impact of Metabolic Syndrome Risk Factors on Lung Function Impairment: Cross-Sectional Study

JMIR Public Health Surveill 2023;9:e43737

DOI: 10.2196/43737

PMID: 37669095

PMCID: 10516148

The impact of metabolic syndrome risk factors on lung function impairment: a cross-sectional study

  • Rafael Molina-Luque; 
  • Guillermo Molina-Recio; 
  • Domingo de Pedro–Jiménez; 
  • Carlos Álvarez–Fernández; 
  • María García–Rodríguez; 
  • Manuel Romero-Saldaña

ABSTRACT

Background:

Metabolic syndrome (MetS) is a constellation of risk factors affecting different organs. Both MetS and its independent risk factors are associated with lung impairment as measured by changes in spirometry variables. Consequently, it is interesting to know whether a higher number of MetS criteria is associated with greater lung function depletion.

Objective:

Determine the association between an increased number of MetS components and respiratory function decline.

Methods:

We conducted a descriptive cross-sectional study with a random sample of 1980 workers. MetS was established based on harmonised criteria, and lung function was assessed according to spirometry variables. Based on these, classification into restrictive (RLD), obstructive (OLD) and mixed (MD) lung disease was established. In addition, the association between MetS and lung function was established based on ANCOVA, linear trend analysis and multiple linear regression.

Results:

MetS was associated with worse lung function, according to all parameters studied, as well as a higher prevalence of RLD and MD (p < 0.001). All MetS risk factors were significantly associated with spirometry parameters after adjusting for several explanatory variables, except FEV1/FVC. An increasing number of MetS criteria was associated with progressive depletion of lung function (p < 0.001). Furthermore, there was a significant linear trend in the increasing prevalence of RLD and MD with the increasing number of MetS criteria.

Conclusions:

The findings have shown that an increase in cardiovascular risk factors is associated with a more significant depletion of spirometry variables and a higher prevalence of restrictive and mixed lung disease.


 Citation

Please cite as:

Molina-Luque R, Molina-Recio G, de Pedro–Jiménez D, Álvarez–Fernández C, García–Rodríguez M, Romero-Saldaña M

The Impact of Metabolic Syndrome Risk Factors on Lung Function Impairment: Cross-Sectional Study

JMIR Public Health Surveill 2023;9:e43737

DOI: 10.2196/43737

PMID: 37669095

PMCID: 10516148

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.